A pioneering new medicine could improve cancer treatment by enhancing the effectiveness of chemotherapy.
Named KCL-HO-1i, the drug operates by dismantling a crucial defence mechanism employed by tumours to shield themselves from treatment.
A pioneering new medicine could improve cancer treatment by enhancing the effectiveness of chemotherapy.
Named KCL-HO-1i, the drug operates by dismantling a crucial defence mechanism employed by tumours to shield themselves from treatment.